The labels of Non-Steroidal Anti-inflammatory Drugs (NSAIDs) carry the risk for heart attacks and heart failure. However, the Food and Drug Administration just strengthened the warning to require manufacturing companies to be more specific about those risks and to add them to all NSAIDs products. Some of these label updates will include the onset as well as people who are at great risk. Although cardiovascular adverse effects can happen at any time and with large doses, they also can occur as early as the first week of usage. People who are a greater risk are those who recently had a cardiac bypass and cardiac arrest. Based on the growing body of evidence, would you consider discussing alternatives for pain control before recommending NSAIDs?
For more information please see FDA
Image courtesy of [Nutdanai Apikhomboonwaroot]/FreeDigitalPhotos.net